Cytek Biosciences to Report Second Quarter 2022 Financial Results on August 10, 2022
20 juil. 2022 16h05 HE
|
Cytek Biosciences, Inc.
FREMONT, Calif., July 20, 2022 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), today announced it will report financial results for the second quarter...
Cytek Biosciences to Host Inaugural Analyst and Investor Day
01 juin 2022 16h05 HE
|
Cytek Biosciences, Inc.
FREMONT, Calif., June 01, 2022 (GLOBE NEWSWIRE) -- Cytek® Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB) announced today that it will host its inaugural Analyst and Investor Day...
Cytek® Biosciences Receives CE Marking for Series of cFluor® Reagents, TBNK Kit
24 mai 2022 10h00 HE
|
Cytek Biosciences, Inc.
FREMONT, Calif., May 24, 2022 (GLOBE NEWSWIRE) -- Clinical flow cytometry laboratories based in Europe can now purchase Cytek cFluor® CE-IVD-certified reagents for their use. Cytek Biosciences, Inc....
Cytek Biosciences Reports First Quarter 2022 Financial Results
11 mai 2022 16h05 HE
|
Cytek Biosciences, Inc.
FREMONT, Calif., May 11, 2022 (GLOBE NEWSWIRE) -- Cytek® Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB) today reported financial results for the first quarter ended March 31,...
Cytek Biosciences to Report First Quarter Financial Results on May 11, 2022
28 avr. 2022 16h05 HE
|
Cytek Biosciences, Inc.
FREMONT, Calif., April 28, 2022 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), today announced it will report financial results for the first quarter...
Cytek Biosciences Appoints Todd Garland Chief Commercial Officer
28 avr. 2022 08h00 HE
|
Cytek Biosciences, Inc.
FREMONT, Calif., April 28, 2022 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced the appointment of Todd Garland as Chief...
Cytek Biosciences Reports Fourth Quarter and Full Year 2021 Financial Results
23 févr. 2022 16h05 HE
|
Cytek Biosciences, Inc.
2021 Revenue Increased 38% Compared to Prior Year FREMONT, Calif., Feb. 23, 2022 (GLOBE NEWSWIRE) -- Cytek® Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB) today reported...
Cytek to Participate in the 42nd Annual Cowen Health Care Conference
16 févr. 2022 16h05 HE
|
Cytek Biosciences, Inc.
FREMONT, Calif., Feb. 16, 2022 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), today announced the company will be participating virtually in the...
Cytek Biosciences to Report Fourth Quarter and Full Year 2021 Financial Results on February 23, 2022
11 févr. 2022 08h00 HE
|
Cytek Biosciences, Inc.
FREMONT, Calif., Feb. 11, 2022 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), today announced it will report financial results for the fourth quarter...
Cytek® Biosciences Expands Fremont Headquarters, Tripling Its Manufacturing Capacity
05 janv. 2022 10h00 HE
|
Cytek Biosciences, Inc.
FREMONT, Calif., Jan. 05, 2022 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced that it has opened a new facility in Fremont,...